ロード中...
Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
INTRODUCTION: Factor Xa (fXa) inhibitor reversal for life-threatening bleeding is controversial due to a lack of high-quality evidence. The purpose of this study was to determine the hemostatic efficacy of four-factor prothrombin complex concentrate (4F-PCC) for the reversal of fXa inhibitors compar...
保存先:
| 出版年: | West J Emerg Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7972353/ https://ncbi.nlm.nih.gov/pubmed/33856296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5811/westjem.2020.11.47931 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|